VistaGen Therapeutics Inc Working Capital to Net Assets Ratio
VistaGen Therapeutics Inc working capital to net assets ratio. VistaGen Therapeutics Inc (VTGN) has a Working Capital to Net Assets ratio of 96.1% as of March 2026. Working capital of $34.15 Million (current assets of $46.94 Million minus current liabilities of $12.79 Million) is measured against net assets of $35.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of VistaGen Therapeutics Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of VistaGen Therapeutics Inc (2008–2026)
Working capital to net assets ratio of VistaGen Therapeutics Inc from 2008 to 2026. This chart shows how VistaGen Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2008 to 2026. As of March 2026, the ratio stands at 96.1%, reflecting working capital of $34.15 Million against net assets of $35.52 Million USD. See how many days can VistaGen Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
VistaGen Therapeutics Inc Working Capital to Net Assets Ratio by Year (2008–2026)
VistaGen Therapeutics Inc working capital to net assets ratio by year from 2008 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for VistaGen Therapeutics Inc from 2008 to 2026, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see VTGN asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 96.1% | $34.15 Million | $35.52 Million | $46.94 Million | $12.79 Million | ▼ -2.5 pp |
| 2025 | 98.7% | $69.46 Million | $70.39 Million | $82.08 Million | $12.61 Million | ▼ -2.4 pp |
| 2024 | 101.1% | $115.55 Million | $114.29 Million | $120.67 Million | $5.12 Million | ▼ -6.0 pp |
| 2023 | 107.1% | $12.93 Million | $12.08 Million | $17.51 Million | $4.57 Million | ▲ +6.3 pp |
| 2022 | 100.8% | $65.23 Million | $64.72 Million | $71.00 Million | $5.77 Million | ▼ -7.8 pp |
| 2021 | 108.6% | $99.93 Million | $91.98 Million | $104.12 Million | $4.19 Million | ▲ +87.9 pp |
| 2020 | 20.8% | $-1.19 Million | $-5.73 Million | $1.58 Million | $2.77 Million | ▼ -132.6 pp |
| 2019 | 153.4% | $10.85 Million | $7.08 Million | $13.65 Million | $2.80 Million | ▲ +15.1 pp |
| 2018 | 138.3% | $9.56 Million | $6.92 Million | $11.02 Million | $1.46 Million | ▼ -188.2 pp |
| 2017 | 326.5% | $2.01 Million | $615.80K | $3.38 Million | $1.37 Million | ▲ +294.9 pp |
| 2016 | 31.6% | $-939.40K | $-2.98 Million | $855.30K | $1.79 Million | ▼ -52.6 pp |
| 2015 | 84.1% | $-17.28 Million | $-20.54 Million | $105.70K | $17.39 Million | ▲ +43.8 pp |
| 2014 | 40.4% | $-5.17 Million | $-12.80 Million | $40.50K | $5.21 Million | ▲ +26.5 pp |
| 2013 | 13.9% | $-1.74 Million | $-12.56 Million | $671.80K | $2.41 Million | ▼ -37.7 pp |
| 2012 | 51.6% | $-2.94 Million | $-5.71 Million | $238.10K | $3.18 Million | ▼ -87.6 pp |
| 2011 | 139.2% | $-1.39K | $-1.00K | $1.81K | $3.20K | ▼ -622.1 pp |
| 2010 | 761.3% | $-944.00 | $-124.00 | $556.00 | $1.50K | ▲ +667.4 pp |
| 2009 | 93.9% | $19.13K | $20.37K | $21.81K | $2.69K | ▼ -6.1 pp |
| 2008 | 100.0% | $-145.00 | $-145.00 | $95.00 | $240.00 | — |